Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TA-02
Cat. No.:
OB0225LY-0290
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
TA-02 is a biologically active compound with specific cytostatic effects.
Synonym:
1784751-19-4; TA 02; TA02; 4-[2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine; 4-(2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine
CAS No.:
1784751-19-4
Compound CID:
91691130
Formula:
C20H13F2N3
Formula Weight:
333.33
Specification
Relative Density:
1.289 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
TA-02 can be used for cell migration studies or play an important role in tumor microenvironment analysis.
Library Information
Targets:
Kinases
Receptors:
p38 MAPK
Pathways:
MAPK; Autophagy
Plate Number:
AOCL-4
Plate Location:
f9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 150 mM
